As a new class of GLP-1 therapies reshapes how millions of people eat, researchers and innovators are increasingly focused on how to ensure the body still gets the nutrients it needs.
That challenge is now being addressed by amplifye, a startup that emerged out of the University of California, Davis, that is translating enzyme research into technologies designed to improve how the body breaks down and absorbs protein.